Comparison 57. IncobotulinumtoxinA 24 units versus OnabotulinumtoxinA 24 units one treatment in glabellar lines.
| Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
|---|---|---|---|---|
| 57.1 Any major adverse events (eyelid ptosis, eyelid sensory disorder, strabismus) | 1 | Peto Odds Ratio (Peto, Fixed, 95% CI) | Totals not selected | |
| 57.2 Physician assessment of success by analysing scores and scales | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 57.2.1 4 weeks | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 57.2.2 12 weeks | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 57.3 Total adverse events | 1 | Peto Odds Ratio (Peto, Fixed, 95% CI) | Totals not selected |